ClinVar Miner

Submissions for variant NM_005249.5(FOXG1):c.759C>A (p.Asn253Lys)

dbSNP: rs767873754
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn RCV001171512 SCV001245456 likely pathogenic Rett syndrome, congenital variant 2020-04-20 criteria provided, single submitter clinical testing The variant c.759C> A; p.(Asn253Lys) in the FOXG1 gene (transcript: NM_005249.4) is not listed in population-related databases (gnomAD, 1OOOGenomes and Exome Variant Server). It is also not listed in the phenotype-related databases HGMD, ClinVar and LOVD. However, the variant c.757A> G; p.(Asn253Asp), which affects the same amino acid, has already been described as pathogenic (see PMID: 21441262). The mutation prediction programs MutationTaster, Polyphen, SIFT and PROVEAN rate the variant as pathogenic, the CADD score is 27.6. The in silica analysis using the Alamut software does not provide any clear indication of a change in splicing behavior with various prediction programs, only the Human Splicing Finder program predicts the generation of a new donor splicing site. The FOXG1 variant was also detected in the patient's brother, who was also affected. The mother was found in one of 132 reads of the sequencing data. Overall, the FOXG1 variant is probably considered pathogenic (PM1, PM2, PM5, PP2, PP3).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.